Kyverna Therapeutics, Inc.
KYTX • NASDAQ • Stock Fundamentals
Kyverna Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Warner Biddle, with a market cap of $523.4M.
Market Cap$523.4M
Employees100.0
CEOWarner Biddle
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Kyverna Therapeutics, Inc. FAQ
Common questions about Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX) has a market capitalization of $523.4M and trades on NASDAQ.
Kyverna Therapeutics, Inc. has approximately 100 employees.